Rhonda Robb Net Worth

The estimated Net Worth of Rhonda J. Robb is at least $5.38 Million dollars as of 7 February 2022. Ms. Robb owns over 1,567 units of Cardiovascular Systems stock worth over $3,282,080 and over the last 7 years she sold CSII stock worth over $152,244. In addition, she makes $1,944,050 as Chief Operating Officer at Cardiovascular Systems.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Ms. Robb CSII stock SEC Form 4 insiders trading

Rhonda has made over 4 trades of the Cardiovascular Systems stock since 2020, according to the Form 4 filled with the SEC. Most recently she bought 1,567 units of CSII stock worth $29,334 on 7 February 2022.

The largest trade she's ever made was selling 3,600 units of Cardiovascular Systems stock on 12 February 2020 worth over $152,244. On average, Rhonda trades about 448 units every 45 days since 2018. As of 7 February 2022 she still owns at least 164,104 units of Cardiovascular Systems stock.

You can see the complete history of Ms. Robb stock trades at the bottom of the page.

Rhonda Robb biography

Rhonda J. Robb serves as Chief Operating Officer of the Company. Ms. Robb held several positions at Medtronic, most recently as Vice President and General Manager of the Heart Valve Therapies Business from 2014 to 2018. From 2009 to 2014, Ms. Robb was Vice President and General Manager for Medtronic’s Catheter Based Therapies business. Ms. Robb was employed by Medtronic since 1990 and has served in several other leadership roles, including Vice President of Global Marketing, Coronary and Peripheral; Director Global Marketing, Heart Failure/High Power Therapies; and Director US Marketing, Cardiac Rhythm & Disease Management.

What is the salary of Rhonda Robb?

As the Chief Operating Officer of Cardiovascular Systems, the total compensation of Rhonda Robb at Cardiovascular Systems is $1,944,050. There are 1 executives at Cardiovascular Systems getting paid more, with Scott Ward having the highest compensation of $4,718,960.

How old is Rhonda Robb?

Rhonda Robb is 52, she's been the Chief Operating Officer of Cardiovascular Systems since 2018. There are 15 older and 10 younger executives at Cardiovascular Systems. The oldest executive at Cardiovascular Systems Inc. is Augustine Lawlor, 64, who is the Independent Director.

What's Rhonda Robb's mailing address?

Rhonda's mailing address filed with the SEC is 1225 OLD HIGHWAY 8 NW, , ST. PAUL, MN, 55112.

Insiders trading at Cardiovascular Systems

Over the last 16 years, insiders at Cardiovascular Systems have traded over $72,999,461 worth of Cardiovascular Systems stock and bought 949,532 units worth $8,687,068 . The most active insiders traders include Capital Management Lp Camber, Augustine Lawlor, and Capital Ltdmaverick Capital.... On average, Cardiovascular Systems executives and independent directors trade stock every 14 days with the average trade being worth of $338,920. The most recent stock trade was executed by Martha Goldberg Aronson on 15 August 2022, trading 2,411 units of CSII stock currently worth $48,220.

What does Cardiovascular Systems do?

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.

Complete history of Ms. Robb stock trades at Cardiovascular Systems

Cardiovascular Systems executives and stock owners

Cardiovascular Systems executives and other stock owners filed with the SEC include:

• Scott Ward,
  Chairman of the Board, President, Chief Executive Officer
• Rhonda Robb,
  Chief Operating Officer
• Scott Raymond Ward B.Sc., M.S., MS,
  Chairman, Pres & CEO
• Scott Raymond Ward M.S., MS, B.Sc.,
  Chairman, Pres & CEO
• Jeffrey Points,
  Chief Financial Officer
• Alexander Rosenstein,
  General Counsel and Corporate Secretary
• Ryan Egeland,
  Chief Medical Officer
• Rhonda J. Robb,
  Chief Operating Officer
• Sandra Sedo,
  Chief Compliance Officer
• Jeffrey S. Points,
  Chief Financial Officer
• Alexander Rosenstein,
  Gen. Counsel & Corp. Sec.
• Dr. Ryan D. Egeland M.D., Ph.D.,
  Chief Medical Officer
• Edward Brown,
  Independent Director
• Augustine Lawlor,
  Independent Director
• Martha Aronson,
  Independent Director
• Erik Paulsen,
  Independent Director
• William Cohn,
  Independent Director
• Stephen Stenbeck,
  Independent Director
• Stephen Rempe,
  Chief Human Resource Officer
• Kelvin Womack,
  Independent Director
• David Whitescarver,
  Vice President - Corporate Development and Intellectual Property
• John Hastings,
  Vice President - Manufacturing and Operations
• Stephen J. Rempe,
  Chief HR Officer
• David S. Whitescarver,
  VP of Corp. Devel. & Intellectual Property
• Sandra M. Sedo,
  Chief Compliance Officer
• John M. Hastings,
  Exec. VP of Operations & Technology
• John E. Nielsen,
  VP of Investor Relations & Corp. Communications
• Brent G Blackey,
  Director
• Leslie Trigg,
  Director
• Capital Management Lp Camber,
  10% owner
• Scott A Bartos,
  Director
• Laurence L Betterley,
  Chief Financial Officer
• Kevin J. Kenny,
  Chief Operating Officer
• Laura Gillund,
  Chief Talent Officer
• Sachin H. Jain,
  Director
• Capital Ltdmaverick Capital...,
  
• Gary M Petrucci,
  Director
• Paul A. Koehn,
  SVP Quality & Operations
• James E Flaherty,
  Chief Administrative Officer
• Glen D Nelson,
  Director
• Robert J Thatcher,
  Executive VP
• David Martin,
  President and CEO
• Geoffrey O Hartzler,
  Director
• Brian Doughty,
  VP of Marketing
• Paul A Tyska,
  VP of Business Dev
• Roger J Howe,
  Director
• Group I, Llc Donoghue Danie...,
  
• John H Friedman,
  Director
• Scott William Kraus,
  VP Sales
• Advisors, Inc Bonderman Dav...,
  
• Geoffrey M Duyk,